EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access

Efficacy of Elagolix and Relugolix for the Treatment of Pelvic Pain in Patients With Endometriosis: A Systematic Review

Mayuri Quishpe, Jesús Endara-Mina, Josselyn Caizapanta, Alisson Guzmán, Dayana Tenesaca, Diana Asto, Odalis Mena, Noelya Rengel, Jorge Avilés, Genesis Vaca, Henry Sarmiento-Vallejo

Cureus · 12.09.2025

DOI: 10.7759/cureus.92149 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 12.09.2025. Verfasst von Mayuri Quishpe und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research, Escuela Superior Politécnica de Chimborazo, Riobamba, ECU. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometriosis is a chronic gynecological condition commonly associated with pelvic pain, dysmenorrhea, dyspareunia, and infertility. Owing to the limitations and adverse effects of traditional hormonal therapies, this study aimed to evaluate the efficacy and safety of elagolix and relugolix for the management of endometriosis-related pain, in comparison with other therapeutic alternatives. A systematic search was conducted in PubMed/Medical Literature Analysis and Retrieval System Online (MEDLINE), Cochrane, SciELO, ScienceDirect, and Google Scholar, including randomized clinical trials (RCTs) published between 2014 and 2025. Methodological quality was assessed using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, together with the GRADE and Jadad tools. Nine clinical trials met the inclusion criteria. The findings suggest that both relugolix and elagolix, whether administered as monotherapy or in combination with estrogens and progestins, effectively reduce endometriosis-associated pain, improve the quality of life, and decrease the need for opioid use. Reported adverse events were generally mild, with minimal loss of bone mineral density (BMD). Importantly, the strongest and most consistent evidence supports the use of relugolix in combination with add-back therapy, which appears to provide sustained efficacy and a more favorable long-term safety profile than monotherapy. Thus, relugolix with hormonal add-back therapy emerges as a safe and effective long-term treatment option for endometriosis-related symptoms, offering significant clinical benefits while mitigating hypoestrogenic side effects.

Schlagwörter

Stichwörter der Autor:innen

dysmenorrheaelagolixendometriosis painob-gynpelvic painrelugolix

Autor:innen und Institutionen

  • Research, Escuela Superior Politécnica de Chimborazo, Riobamba, ECU.
  • Research, Eugenio Espejo Specialties Hospital, Quito, ECU.
  • Research, Universidad Regional Autónoma de Los Andes, Santo Domingo, ECU.
  • Research, Ministry of Public Health, Loja, ECU.
  • Research, Ministry of Public Health, Quito, ECU.
  • Obstetrics and Gynecology, University of the Americas, Quito, ECU.

Zitieren

APA

Quishpe, M., Endara-Mina, J., Caizapanta, J., Guzmán, A., Tenesaca, D., Asto, D., Mena, O., Rengel, N., Avilés, J., Vaca, G., & Sarmiento-Vallejo, H. (2025). Efficacy of Elagolix and Relugolix for the Treatment of Pelvic Pain in Patients With Endometriosis: A Systematic Review. Cureus. https://doi.org/10.7759/cureus.92149

Vancouver

Quishpe M, Endara-Mina J, Caizapanta J, Guzmán A, Tenesaca D, Asto D, et al. Efficacy of Elagolix and Relugolix for the Treatment of Pelvic Pain in Patients With Endometriosis: A Systematic Review. Cureus. 2025. doi:10.7759/cureus.92149

BibTeX
@article{Quishpe2025,
  author = {Quishpe, Mayuri and Endara-Mina, Jesús and Caizapanta, Josselyn and Guzmán, Alisson and Tenesaca, Dayana and Asto, Diana and Mena, Odalis and Rengel, Noelya and Avilés, Jorge and Vaca, Genesis and Sarmiento-Vallejo, Henry},
  title = {Efficacy of Elagolix and Relugolix for the Treatment of Pelvic Pain in Patients With Endometriosis: A Systematic Review},
  journal = {Cureus},
  year = {2025},
  doi = {10.7759/cureus.92149}
}
Kostenlos starten →